The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome
Abstract
Objective: Because it has no unique clinical, biologic, or histologic features, reactive hemophagocytic syndrome may be difficult to distinguish from other diseases such as severe sepsis or hematologic malignancies. This study was undertaken to develop and validate a diagnostic score for reactive hemophagocytic syndrome. Methods: A multicenter retrospective cohort of 312 patients who were judged by experts to have reactive hemophagocytic syndrome (n = 162), were judged by experts to not have reactive hemophagocytic syndrome (n = 104), or in whom the diagnosis of reactive hemophagocytic syndrome was undetermined (n = 46) was used to construct and validate the reactive hemophagocytic syndrome diagnostic score, called the HScore. Ten explanatory variables were evaluated for their association with the diagnosis of hemophagocytic syndrome, and logistic regression was used to calculate the weight of each criterion included in the score. Performance of the score was assessed using developmental and validation data sets. Results: Nine variables (3 clinical [i.e., known underlying immunosuppression, high temperature, organomegaly], 5 biologic [i.e., triglyceride, ferritin, serum glutamic oxaloacetic transaminase, and fibrinogen levels, cytopenia], and 1 cytologic [i.e., hemophagocytosis features on bone marrow aspirate]) were retained in the HScore. The possible number of points assigned to each variable ranged from 0–18 for known underlying immunosuppression to 0–64 for triglyceride level. The median HScore was 230 (interquartile range [IQR] 203–257) for patients with a positive diagnosis of reactive hemophagocytic syndrome and 125 (IQR 91–150) for patients with a negative diagnosis. The probability of having hemophagocytic syndrome ranged from <1% with an HScore of ≤90 to >99% with an HScore of ≥250. Conclusion: The HScore can be used to estimate an individual's risk of having reactive hemophagocytic syndrome. This scoring system is freely available online (http://saintantoine.aphp.fr/score/).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
A REVIEW OF GOODNESS OF FIT STATISTICS FOR USE IN THE DEVELOPMENT OF LOGISTIC REGRESSION MODELS1
LEMESHOW, S., & HOSMER, D. W. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113284 · Cited by 1,947
Infections associated with haemophagocytic syndrome
Rouphael, N. G., Talati, N. J., Vaughan, C., Cunningham, K., Moreira, R., & Gould, C. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70290-6 · Cited by 596
Familial and Acquired Hemophagocytic Lymphohistiocytosis
Janka, G. E. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-041610-134208 · Cited by 549
Ravelli, A., Magni-Manzoni, S., Pistorio, A., Besana, C., Foti, T., Ruperto, N., Viola, S., & Martini, A. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.016 · Cited by 415
Fukaya, S., Yasuda, S., Hashimoto, T., Oku, K., Kataoka, H., Horita, T., Atsumi, T., & Koike, T. (2008) · Rheumatology · doi:10.1093/rheumatology/ken342 · Cited by 337
Dhote, R., Simon, J., Papo, T., Detournay, B., Sailler, L., Andre, M., Dupond, J., Larroche, C., Piette, A., Mechenstock, D., et al. (2003) · Arthritis Care & Research · doi:10.1002/art.11368 · Cited by 321
Imashuku (1997) · International Journal of Hematology · doi:10.1016/s0925-5710(97)00584-7 · Cited by 265
Thrombocytopenia in the Sepsis Syndrome
François, B., Trimoreau, F., Vignon, P., Fixe, P., Praloran, V., & Gastinne, H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00136-8 · Cited by 248
Cited by
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045
“HScore is proposed as a classification tool for secondary MAS, and values more than 169 are highly diagnostic (Fardet et al., 2014).”
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,565
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
La Rosée, P., Horne, A., Hines, M., von Bahr Greenwood, T., Machowicz, R., Berliner, N., Birndt, S., Gil-Herrera, J., Girschikofsky, M., Jordan, M. B., et al. (2019) · Blood · doi:10.1182/blood.2018894618 · Cited by 1,108
COVID-19 and Multiorgan Response
Zaim, S., Chong, J. H., Sankaranarayanan, V., & Harky, A. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100618 · Cited by 1,022
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 520
Hemophagocytic Lymphohistiocytosis
Al-Samkari, H., & Berliner, N. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043625 · Cited by 506
A comprehensive review on adult onset Still's disease
Giacomelli, R., Ruscitti, P., & Shoenfeld, Y. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.018 · Cited by 419
How I treat hemophagocytic lymphohistiocytosis in the adult patient
Schram, A. M., & Berliner, N. (2015) · Blood · doi:10.1182/blood-2015-01-551622 · Cited by 414
Cardiovascular manifestations and treatment considerations in COVID-19
Kang, Y., Chen, T., Mui, D., Ferrari, V., Jagasia, D., Scherrer-Crosbie, M., Chen, Y., & Han, Y. (2020) · Heart · doi:10.1136/heartjnl-2020-317056 · Cited by 411
Mechanisms, biomarkers and targets for adult-onset Still’s disease
Feist, E., Mitrovic, S., & Fautrel, B. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0081-x · Cited by 394
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Fara, A., Mitrev, Z., Rosalia, R. A., & Assas, B. M. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 369
Rejeski, K., Subklewe, M., Aljurf, M., Bachy, E., Balduzzi, A., Barba, P., Bruno, B., Benjamin, R., Carrabba, M. G., Chabannon, C., et al. (2023) · Blood · doi:10.1182/blood.2023020578 · Cited by 358
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy
Griffin, G., Shenoi, S., & Hughes, G. C. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101515 · Cited by 349
Hayden, A., Park, S., Giustini, D., Lee, A. Y. Y., & Chen, L. Y. C. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.05.001 · Cited by 338
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Hines, M. R., Knight, T. E., McNerney, K. O., Leick, M. B., Jain, T., Ahmed, S., Frigault, M. J., Hill, J. A., Jain, M. D., Johnson, W. T., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.03.006 · Cited by 338
Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients
Rivière, S., Galicier, L., Coppo, P., Marzac, C., Aumont, C., Lambotte, O., & Fardet, L. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.04.034 · Cited by 324
Self-citationMacrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
Karakike, E., & Giamarellos-Bourboulis, E. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00055 · Cited by 304
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
Webb, B. J., Peltan, I. D., Jensen, P., Hoda, D., Hunter, B., Silver, A., Starr, N., Buckel, W., Grisel, N., Hummel, E., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30343-x · Cited by 293
Mehta, P., Cron, R. Q., Hartwell, J., Manson, J. J., & Tattersall, R. S. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30096-5 · Cited by 285
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Eloseily, E. M., Weiser, P., Crayne, C. B., Haines, H., Mannion, M. L., Stoll, M. L., Beukelman, T., Atkinson, T. P., & Cron, R. Q. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41103 · Cited by 282
Román, G. C., Spencer, P. S., Reis, J., Buguet, A., Faris, M. E. A., Katrak, S. M., Láinez, M., Medina, M. T., Meshram, C., Mizusawa, H., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116884 · Cited by 280
Landewé, R. B., Machado, P. M., Kroon, F., Bijlsma, H. W., Burmester, G. R., Carmona, L., Combe, B., Galli, M., Gossec, L., Iagnocco, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217877 · Cited by 262
Carter, S. J., Tattersall, R. S., & Ramanan, A. V. (2019) · Rheumatology · doi:10.1093/rheumatology/key006 · Cited by 259
Manson, J. J., Crooks, C., Naja, M., Ledlie, A., Goulden, B., Liddle, T., Khan, E., Mehta, P., Martin-Gutierrez, L., Waddington, K. E., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30275-7 · Cited by 258
Preliminary predictive criteria for COVID-19 cytokine storm
Caricchio, R., Gallucci, M., Dass, C., Zhang, X., Gallucci, S., Fleece, D., Bromberg, M., & Criner, G. J. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218323 · Cited by 230
Schulert, G. S., Zhang, M., Fall, N., Husami, A., Kissell, D., Hanosh, A., Zhang, K., Davis, K., Jentzen, J. M., Napolitano, L., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv550 · Cited by 170
The looming storm: Blood and cytokines in COVID-19
Kaur, S., Bansal, R., Kollimuttathuillam, S., Gowda, A. M., Singh, B., Mehta, D., & Maroules, M. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100743 · Cited by 113
Zhang, M., Bracaglia, C., Prencipe, G., Bemrich-Stolz, C. J., Beukelman, T., Dimmitt, R. A., Chatham, W. W., Zhang, K., Li, H., Walter, M. R., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501284 · Cited by 99
Metadata
- Authors
- Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., Coppo, P., & Hejblum, G.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2014-08-26
- Volume
- 66
- Issue
- 9
- Pages
- 2613-2620
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W1505641753
- Cited by
- 1,475
- References
- 26
- FWCI
- 15.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.